Abstract 41: Cerebral Microbleeds and the Effect of Anticoagulation on Outcomes in 3699 Patients With Embolic Strokes of Undetermined Source: An Exploratory Analysis of the NAVIGATE ESUS Trial

Stroke - United States
doi 10.1161/str.50.suppl_1.41
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

NAVIGATE ESUS: Phase-Iii RCT Assessing Prevention of Stroke and Systemic Embolism in Patients With Embolic Stroke of Undetermined Source

Journal of the Neurological Sciences
Neurology
2015English

Diagnostic Considerations of Embolic Strokes of Undetermined Source on Admission

Neurosonology
2015English

Relationship Between Lambl’s Excrescences and Embolic Strokes of Undetermined Source

European Stroke Journal
NeurologyCardiovascular MedicineCardiology
2020English

Pulmonary Arteriovenous Malformation Can Be Associated With Embolic Stroke of Undetermined Source (ESUS)

European Journal of Case Reports in Internal Medicine
Internal Medicine
2019English

Embolic Strokes of Undetermined Source: Theoretical Construct or Useful Clinical Tool?

Therapeutic Advances in Neurological Disorders
NeurologyPharmacology
2019English

Higher Bleeding Rates in Patients Taking Rivaroxaban Following an Embolic Stroke of Undetermined Source

Journal of Pharmacy Practice and Research
PharmacologyPharmacy
2019English

Antithrombotic Therapy for Cerebral Embolism: How to Interpret the Results of NAVIGATE ESUS and RE-SPECT ESUS Trials

Japanese Journal of Thrombosis and Hemostasis
2019English

Embolic Stroke of Undetermined Source in a Young Woman

American Journal of Hematology
Hematology
2019English

Frequency and Features of Embolic Stroke of Undetermined Source in Young Adults

European Stroke Journal
NeurologyCardiovascular MedicineCardiology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy